Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Diabetes: Daily Aspirin or Other Antiplatelet for Diabetes Patients with Ischemic Vascular Disease (IVD) Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 11 Clinics in the Mayo Clinic Health System health system


The results below represent the care of 362 patients with Diabetes. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
CLINIC_NAME

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in Arcadia

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in Caledonia

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in Holmen

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in La Crescent

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in La Crosse
N=209
98.09 %
View Historical Data
Mayo Clinic Health System - Franciscan Healthcare in Onalaska
N=153
95.42 %
View Historical Data
Mayo Clinic Health System - Franciscan Healthcare in Prairie du Chien

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in Sparta

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in Tomah

The number of patients or providers is too small for
purposes of reliably reporting performance
Mayo Clinic Health System - Franciscan Healthcare in Waukon

The number of patients or providers is too small for
purposes of reliably reporting performance

Based on trials involving other secondary prevention therapies, the American College of Cardiology (ACC) and the American Heart Assocation (AHA) recommends aspirin in all patients, unless contraindicated, with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. The ACC and AHA also recommend the use of other antiplatelet agents based on disease type and clinical conditions. The American Diabetes Association (ADA) supports this recommendation as a secondary prevention strategy for type 1 or type 2 diabetes with a history of cardiovascular disease.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.